Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 4, 2011, Pages 301-309

  Boncler, Magdalena ^a   Rywaniak, Joanna ^a   Sicinska, Paulina ^b   Watala, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

albumin; blood platelets; C reactive protein; globulin; plasma proteins

Indexed keywords

ALBUMIN; ALPHA GLOBULIN; BETA GLOBULIN; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; C-REACTIVE PROTEIN; CELLS, CULTURED; CLONING, MOLECULAR; ESCHERICHIA COLI; FIBRINOGEN; FLOW CYTOMETRY; GAMMA-GLOBULINS; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET-RICH PLASMA; PROTEIN BINDING; RECOMBINANT PROTEINS; SERUM ALBUMIN; SUSPENSIONS;

EID: 79955968942     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283451308     Document Type: Article

References (35)

1. Kresl JJ, Potempa LA, Anderson BE. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein. Int J Biochem Cell Biol 1998; 30:1415-1426. (Pubitemid 129750174)
2. Diehl EE, Haines GK III, Radosevich JA, Potempa LA. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am J Med Sci 2000; 319:79-83. (Pubitemid 30349650)
3. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18:1386-1392. (Pubitemid 28421875)
4. Schwedler SB, Guderian F, Dammrich J, Potempa LA, Wanner C. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol Dial Transplant 2003; 18:2300-2307. (Pubitemid 37336817)
5. Ciubotaru I, Potempa LA, Wander RC. Production of modified C-reactive protein in U937-derived macrophages. Exp Biol Med (Maywood) 2005; 230:762-770. (Pubitemid 41565946)
6. Fiedel BA, Simpson RM, Gewurz H. Activation of platelets by modified Creactive protein. Immunology 1982; 45:439-447. (Pubitemid 12165608)
7. Khreiss T, Jozsef L, Potempa LA, Filep JG. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 2004; 109:2016-2022. (Pubitemid 38544493)
8. Khreiss T, Jozsef L, Potempa LA, Filep JG. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 2004; 110:2713-2720. (Pubitemid 39453024)
9. Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 1988; 12:391-405.
10. Zouki C, Haas B, Chan JS, Potempa LA, Filep JG. Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophilendothelial cell adhesion. J Immunol 2001; 167:5355-5361. (Pubitemid 33009775)
11. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 1999; 190:585-590. (Pubitemid 29395386)
12. Crowell RE, Du Clos TW, Montoya G, Heaphy E, Mold C. C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI. J Immunol 1991; 147:3445-3451.
13. Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 2005; 25:1359-1363. (Pubitemid 40923352)
14. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW. C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 1995; 155:2185-2193.
15. Filep JG, Herman F, Kelemen E, Foldes-Filep E. C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res 1991; 61:411-421.
16. Vigo C. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. J Biol Chem 1985; 260:3418-3422. (Pubitemid 15115258)
17. Salonen EM, Vartio T, Hedman K, Vaheri A. Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem 1984; 259:1496-1501. (Pubitemid 14104199)
18. Swanson SJ, McPeek MM, Mortensen RF. Characteristics of the binding of human C-reactive protein (CRP) to laminin. J Cell Biochem 1989; 40:121-132. (Pubitemid 19146206)
19. Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2006; 26:935-941.
20. Boguslawski G, McGlynn PW, Potempa LA, Filep JG, Labarrere CA. Conduct unbecoming: C-reactive protein interactions with a broad range of protein molecules. J Heart Lung Transplant 2007; 26:705-713. (Pubitemid 47001707)
21. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den BB, Reitsma PH, et al. Activation of inflammation and coagulation after infusion of Creactive protein in humans. Circ Res 2005; 96:714-716. (Pubitemid 40559509)
22. Fine KM, Ashbrook PC, Brigden LP, Maldonado JE, Didishelm P. Gelfiltered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin. Am J Pathol 1976; 84:11-24.
23. Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem 2002; 277:40775-40781. (Pubitemid 35215662)
24. Ji SR, Wu Y, Potempa LA, Qiu Q, Zhao J. Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified Creactive protein in atherosclerosis. Int J Biochem Cell Biol 2006; 38:648-661. (Pubitemid 43117588)
25. Walkowiak B, Kralisz U, Michalec L, Majewska E, Koziolkiewicz W, Ligocka A, Cierniewski CS. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 2000; 99:495-502.
26. Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 1989; 56:763-766. (Pubitemid 20027441)
27. English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1974; 5:249-252.
28. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest 1968; 97:77.
29. Boncler M, Luzak B, Rozalski M, Golanski J, Rychlik B, Watala C. Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. Thromb Res 2006; 119:209-216.
30. Watala C, Boncler M, Golanski J, Koziolkiewicz W, Walkowiak B, Cierniewski CS. Release of calcium and P-selectin from intraplatelet granules is hampered by procaine. Thromb Res 1999; 94:1-11. (Pubitemid 29170395)
31. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216:444-450. (Pubitemid 24076032)
32. Eriksson AC, Whiss PA. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods 2005; 52:356-365. (Pubitemid 41526981)
33. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96:781-788. (Pubitemid 44883819)
34. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-929.
35. Nocun M, Golanski J, Lapshina E, Zavodnik L, Dobaczewski M, Kazmierczak P, et al. Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness: a multiparametric study in rats. Clin Chem Lab Med 2006; 44:853-862.